Merck KGaA (XTRA:MRK) signed a definitive agreement to acquire HUB Organoids B.V. on December 17, 2024. The transaction is expected to close at the end of December 2024.

Raymond James Financial, Inc. acted as financial advisor for HUB Organoids B.V. Hanneke Rothbarth, Lars Meyer, Bob van Kasteren, Michael Ramb, Brechje Nollen and Mark Egeler of Freshfields LLP acted as legal advisor to Merck KGaA in the transaction.